Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for alpelisib (ALP)-induced hyperglycemia: A report of 6 cases from SOLAR-1

dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorLu, Y-S.
dc.contributor.authorChiu, J.
dc.contributor.authorAiroldi, M.
dc.contributor.authorMargeli Vila, M.
dc.contributor.authorPonce Lorenzo, J.
dc.contributor.authorGhaznawi, F.
dc.contributor.authorGaudenzi, F.
dc.contributor.authorRidolfi, A.
dc.contributor.authorLorenzo, I.
dc.contributor.authorRuiz Borrego, M.
dc.contributor.authoraffiliation[Lu, Y-S.] Natl Taiwan Univ Hosp, Med Oncol, Taipei, Taiwan
dc.contributor.authoraffiliation[Chiu, J.] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China
dc.contributor.authoraffiliation[Airoldi, M.] San Giovanni Battista Hosp, Dept Med Oncol, Turin, Italy
dc.contributor.authoraffiliation[Margeli Vila, M.] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain
dc.contributor.authoraffiliation[Ponce Lorenzo, J.] Univ Gen Hosp Alicante, Dept Med Oncol, Alicante, Spain
dc.contributor.authoraffiliation[Ghaznawi, F.] Novartis Pharmaceut, Oncol, E Hanover, NJ USA
dc.contributor.authoraffiliation[Gaudenzi, F.] Novartis Pharma AG, Oncol, Basel, Switzerland
dc.contributor.authoraffiliation[Ridolfi, A.] Novartis Pharma SAS, Oncol, Paris, France
dc.contributor.authoraffiliation[Lorenzo, I.] Novartis Pharma SAS, Oncol, Paris, France
dc.contributor.authoraffiliation[Ruiz Borrego, M.] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain
dc.contributor.funderNovartis Pharmaceuticals Corporation
dc.date.accessioned2025-01-07T15:32:10Z
dc.date.available2025-01-07T15:32:10Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.403
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420403990/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27217
dc.identifier.wosID573469100301
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS363-S363
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleSodium-glucose cotransporter-2 (SGLT-2) inhibitors for alpelisib (ALP)-induced hyperglycemia: A report of 6 cases from SOLAR-1
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files